Abstract:Objective To evaluate the efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis.Methods This is a multieenter,randomized,doubleblind,and positive drug parallel controlled clinical trial.The patients with allergic rhinitis and who met the eligibility criteria were enrolled and divided into the test group and the control group.The patients in the test group received beclometasone dipropionate aqueous nasal spray and the patients in the control group received beclometasone dipropionate nasal spray.All patients in the 2 groups were administered two inhalations of beclomethasone dipropionate into each nostril twice daily(each inhalation contains beclometasone dipropionate 50 μg) for 14 days.The efficacy of these two drugs was evaluated according to the total scores of symptoms of rhinitis,scores of signs and quality of life and percentage changes of patients in three scores mentioned above when the treatment was over.The safety of these two drugs was evaluated according to the incidence of adverse events/adverse reactions,the results of laboratory tests,and ECG when the treatment was over.Results A total of 239 patients were included into the efficacy analysis.Of them,120 patients were in the test group and 119 were in the control group.There was no significant differences in gender, age,rhinitis symptoms,and signs before the drug administration between the 2 groups(P>0.05).The total scores of symptoms of rhinitis,scores of signs and quality of life on days 7 and 14 of treatment decreased significantly as compared with those obtained before the treatment in the both groups(P<0.05), but there was no significant difference in the extent of decrease between the 2 groups(P>0.05).When the treatments were over,the differences in the percentage changes of patients of rhinitis symptoms,signs and quality of life scores before and after treatments in the both 2 groups were statistically significant(P< 0.05),but there was no significant difference between the 2 groups(P>0.05).A total of 241 patients were included into the safety analysis.Of them,121 patients were in the test group and 120 were in the control group.There were 12 adverse events in 10 patients in the test group.Of them,2 events in the 2 patients were adverse drug reactions,including 1 case with throat discomfort and another case with nose bleeding.There were 20 adverse events in the 13 patients in the control group.Of them,11 events in 7 patients were adverse drug reactions and nose bleeding and dry nose were their major manifestations.There was no significant difference in the incidence of adverse events between the 2 groups(P>0.05).No severe adverse events occurred during the clinical trial.Conclusion Beclometasone dipropionate aqueous nasal spray could effectively control the symptoms of allergic rhinitis and its efficacy and safety were similar to those of beclometasone dipropionate nasal spray.

Study on Therapeutic Effect of Complex Prescription Cromolyn Sodium Nasal Spray in the Treatment of Allergic Rhinitis

Randomized Controlled Trial of Compound Loratadine Capsule in the Treatment of Allergic Rhinitis

Efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis:a multicenter,randomized,double-blind,and controlled trial

Efficacy of Loratadine Combined with Budesonide Nasal Spray in the Treatment of Allergic Rhinitis and its Effect on Th1/Th2 Cytokines

Evaluation of the Efficacy and Safety of Desloratadine in Treating Allergic Rhinitis

Clinical study of the combination therapy with intranasal antihistamine and nasal corticosteroids in the treatment of nasal obstruction of persistent non-allergic rhinitis

Acupuncture for Moderate to Severe Allergic Rhinitis: A Non-Randomized Controlled Trial.

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% Versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-severe Allergic Rhinitis.

Randomized Controlled Clinical Trial on Azelastine Hydrochloride Tablet Versus Loratadine in the Treatment of Allergic Rhinitis

Effect of Loratadine Tablets in Combination with Other Drugs on Nasal Physiological Function and T Lymphocyte Subsets in Patients with Allergic Rhinitis

Comparative Efficacy of Mometasone Nasal Spray Combined with Different Doses of Desloratadine, and Montelukast in Childhood Allergic Rhinitis: A Randomized Clinical Trial

Randomized Controlled Clinical Trial Comparing Budesonide Plus Montelukast and Loratadine Plus Montelukast for Treatment of Moderate and Severe Persistent Allergic Rhinitis

Evaluation of the Efficacy of Olopatadine Hydrochloride in the Treating Allergic Rhinitis:A Multicenter,Randomized,Double-blind,Double-dummy Study

Azelastine nasal spray in treating perennial allergic rhinitis: a randomly double-blind trial

Efficacy and Safety of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis: a Randomized Controlled Trial

Clinical study on Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis

Observation of budesonide nasal spraying agent on clinic therapy in chronic rhinitis

Efficacy of combined therapy and maintenance treatment with intranasal glucocorticoid on allergic rhinitis

Clinical Study of Hydrogen-Rich Saline in the Treatment of Moderate to Severe Allergic Rhinitis

To Investigate the Effect of Pretreatment with Budesonide Spray in Patients with Allergic Rhinitis

Analysis of the efficacy of azelastine nasal spray combined with mussel mucin in the treatment of allergic rhinitis and the influence of peripheral blood CCL26 and CCR3 levels.